Table 1.
Demographic and clinical data in the OAB and control groups.
| Control (n = 74) | OAB (n = 73) | p-value | ||
|---|---|---|---|---|
| Demographics | Age Mean | 53.9375 | 57.3889 | 0.117 |
| BMI mean | 26.7973 | 27.9701 | 0.980 | |
| SUI | 15 (20%) | 60 (82%) | <0.001 | |
| Prolapse | 6 (8%) | 32 (44%) | <0.001 | |
| Voiding dysfunction | 30 (41%) | 1 (1%) | <0.001 | |
| Dysuria | 7 (9%) | 0 (0%) | <0.001 | |
| Previous surgery | All | 10 (13.5%) | 25 (34%) | <0.001 |
| TAH | 6 (8.1%) | 17 (23.3%) | – | |
| VH+- PFR | 2 (2.7%) | 3 (4.1%) | – | |
| PFR | 3 (4.1%) | 4 (5.5%) | – | |
| Manchester Repair | 1 (1.4%) | – | ||
| Previous incontinence surgery | All | 1 (1%) | 5 (7%) | 0.014 |
| TVT=1 | 1 (1.4%) | 2 (2.7%) | – | |
| TVT-O/TOT=2 | 2 (2.7%) | – | ||
| Bladder sling | 1(1.4%) | – |
Both groups were comparable for age and BMI but had significant differences in the presence of SUI, prolapse symptoms, voiding dysfunction, dysuria, and previous surgery. SUI, Stress urinary Incontinence; TAH, Total Abdominal Hysterectomy; VH± PFR, Vaginal hysterectomy ± Pelvic floor repair; PFR, Pelvic floor repair; TVT, Transvaginal tape; TVT-O, Transvaginal tape-obturator; TOT, Trans-obturator tape.